NCT01458366 2025-04-30Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and EtoposideThomas Jefferson UniversityPhase 1/2 Completed38 enrolled 17 charts
NCT04666038 2025-04-20BRUIN CLL-321Eli Lilly and CompanyPhase 3 Active not recruiting238 enrolled 17 charts 3 FDA